Connect with us

Press Release

Kalshi Trading Bot Launches Advanced Automated Copy Trading Platform for Prediction Markets

Published

3 weeks ago

on

New platform enables traders to automatically mirror successful prediction market strategies with sophisticated risk management and real-time execution capabilities

United States, 11th Feb 2026 – The Kalshi Trading Bot platform was developed in response to feedback from prediction market participants who expressed interest in accessing successful trading strategies without dedicating substantial time to market research. Traditional approaches to prediction market trading often require significant expertise in both market analysis and technical implementation, creating barriers for many potential participants.

“Prediction markets have proven their value in aggregating collective intelligence and forecasting outcomes across various domains,” noted industry observers. “However, the technical complexity has limited participation from those who could benefit from these markets. Automated copy trading solutions represent an important step toward broader market accessibility.“

The platform operates through a straightforward mechanism: users select experienced traders from a transparent leaderboard displaying verified performance metrics, configure their risk parameters according to personal preferences, and allow the system to automatically execute corresponding trades in their accounts. This approach maintains user control over capital while automating the execution process.

Technical Architecture and Security Features

The technical infrastructure supporting the Kalshi Trading Bot incorporates several features designed to address common concerns in automated trading systems. The platform utilizes a non-custodial architecture, meaning users maintain direct control of their Kalshi accounts and funds throughout the trading process. This design choice addresses security concerns that often arise with automated trading platforms.

Real-time synchronization capabilities ensure that trades are executed promptly when source traders take positions, minimizing slippage and maintaining the integrity of the copy trading strategy. The system monitors selected traders continuously and replicates their market positions according to user-defined parameters.

Risk management tools embedded within the platform allow users to establish position size limits, set maximum loss thresholds, and define which types of markets they wish to participate in. These controls provide safeguards against excessive exposure while maintaining the benefits of automated execution.

Platform Features and Functionality

The www.kalshitradingbot.net platform includes several components designed to support effective copy trading operations. A comprehensive leaderboard displays performance metrics for available traders, including historical returns, win rates, and trading activity patterns. This transparency enables users to make informed decisions about which traders to follow.

The system supports simultaneous copying of multiple traders, allowing users to diversify their approach by following different strategies across various market segments. Configuration options let users adjust the allocation percentages for each followed trader, creating customized portfolio compositions aligned with individual risk tolerances.

Performance tracking dashboards provide users with detailed insights into their copy trading results, including breakdowns by followed trader, market category, and time period. These analytics help users refine their selection of traders to follow and optimize their overall approach to Kalshi trade automation.

Market Context and Industry Trends

The launch of this platform occurs amid growing interest in prediction markets as tools for forecasting political outcomes, economic indicators, and various other events. Kalshi, as a regulated prediction market exchange operating in the United States, has attracted increasing participation from both retail and institutional market participants.

Copy trading mechanisms have proven successful in other financial markets, with millions of users globally utilizing similar systems in forex, cryptocurrency, and equity trading contexts. The adaptation of this approach to prediction markets represents a logical evolution, bringing proven automation concepts to an emerging market segment.

Industry analysts suggest that automated trading tools may contribute to increased liquidity in prediction markets by enabling more consistent participation from a broader range of market participants. Enhanced liquidity typically results in tighter bid-ask spreads and more efficient price discovery, potentially benefiting the overall market ecosystem.

User Experience and Accessibility

The platform emphasizes accessibility for users regardless of their technical background. The onboarding process requires only a Kalshi account connection and basic parameter configuration. No programming knowledge, API management, or technical infrastructure is necessary, lowering barriers to entry for those interested in automated Kalshi trade execution.

Mobile responsiveness ensures that users can monitor their copy trading activities across devices, with real-time notifications alerting them to significant events such as new positions opened or risk thresholds approached. This flexibility allows participants to maintain oversight of their trading operations without requiring constant manual attention.

Support resources including documentation, tutorials, and customer assistance channels help users navigate the platform effectively and understand the implications of different configuration choices. Educational materials explain key concepts in copy trading and provide guidance on evaluating trader performance metrics.

Risk Considerations and User Responsibility

While automated copy trading offers convenience and access to experienced strategies, the platform emphasizes that users retain full responsibility for their trading decisions. Past performance of followed traders does not guarantee future results, and prediction market trading inherently involves risk of capital loss.

The platform encourages users to carefully review trader performance histories, understand the markets those traders typically participate in, and configure risk parameters appropriate to their individual circumstances. Diversification across multiple traders and conservative position sizing are recommended as prudent risk management approaches.

Transparency in fees and costs allows users to understand the economic implications of using the platform. Clear disclosure of subscription pricing, transaction costs, and any other associated fees enables informed decision-making about the overall value proposition.

Future Development and Platform Evolution

The development roadmap for the platform includes planned enhancements based on user feedback and evolving market conditions. Potential additions include expanded analytics capabilities, additional risk management tools, and enhanced social features enabling interaction among platform users.

Integration with additional prediction market platforms may be explored as the ecosystem expands, potentially allowing users to implement copy trading strategies across multiple venues from a single interface. Such expansion would depend on market demand and technical feasibility considerations.

The platform also plans to introduce features supporting advanced users, such as custom strategy creation tools and more granular control over trade execution parameters. These enhancements would maintain the platform’s accessibility for newcomers while providing depth for experienced traders seeking greater customization.

Availability and Access

The platform is now accessible to users with existing Kalshi accounts. Interested parties can visit www.kalshitradingbot.net to create an account, explore the trader leaderboard, and configure their automated copy trading preferences. Multiple subscription tiers accommodate different usage levels and feature requirements.

The launch represents an entry point for those who have been observing prediction markets but hesitated to participate due to time constraints or uncertainty about strategy development. By automating the process of following successful traders, the platform reduces operational complexity while maintaining user control over risk parameters and capital allocation.

Conclusion

The introduction of automated copy trading functionality to the Kalshi prediction market ecosystem reflects broader trends toward accessibility and automation in financial markets. By combining proven copy trading concepts with the unique characteristics of prediction markets, the platform offers an alternative approach for market participation.

As prediction markets continue evolving as tools for information aggregation and forecasting, platforms that lower participation barriers while maintaining robust risk management may contribute to deeper, more liquid markets benefiting all participants. The success of this approach will ultimately be determined by user adoption patterns and the platform’s ability to deliver value to its community.

Media Contact

Organization: Kalshi Trading Bot

Contact Person: Alvis Koepp

Website: https://www.kalshitradingbot.net/

Email: Send Email

Country:United States

Release id:41239

The post Kalshi Trading Bot Launches Advanced Automated Copy Trading Platform for Prediction Markets appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

file

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Related Topics:
Continue Reading

Press Release

CMS(867.HK/8A8.SG): Self-Developed INHBE-Targeting siRNA Drug Received IND Approval for Overweight/Obesity

Published

36 minutes ago

on

March 5, 2026

By

SHENZHEN, CHINA – China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that self-developed innovative drug INHBE-targeting small nucleic acid drug CMS-D008 injection (“CMS-D008”) received the Drug Clinical Trial Approval Notice issued by National Medical Products Administration (“NMPA”) on 4 March 2026. The NMPA has approved the conduct of clinical trials of CMS-D008 injection for overweight or obese individuals.

About CMS-D008

CMS-D008 is a novel siRNA therapy administered by subcutaneous injection. CMS-D008 targets and reduces the hepatic expression of the inhibin subunit beta E (INHBE) gene and lowers the level of Activin E protein encoded by INHBE, which blocks Activin E-ALK7 signaling and reduces fat accumulation effectively. Preclinical studies suggested that CMS-D008 efficiently and sustainably suppressed INHBE expression. In the diet-induced obesity model, CMS-D008 enhanced weight loss by reducing fat mass while retaining lean mass with a good safety profile. It demonstrates potentially better prospects for high-quality, long-term weight loss that boosts fat-specific loss while preserving muscle mass. In the future, it may be developed for the treatment of overweight/obesity, abdominal obesity, and related metabolic diseases.

Fat Loss, muscle preserved: a potentially better therapeutic option for overweight/obesity

Overweight or obesity is a chronic, progressive, relapsing disease characterized by excessive accumulation or abnormal distribution or function of body fat[1]. World Obesity Atlas 2025 Report projected that the global proportion of overweight and obese adults will rise to 50%, with nearly 3 billion adults impacted by high body mass index (BMI), and the population of adults who are overweight or obese in China is projected to reach 515 million by 2030[2]. Existing GLP-1RAs have been proven to be effective for the treatment of overweight and obesity. The main actions of GLP-1RAs are to suppress appetite by acting on the central nervous system and to delay gastric emptying[3]. INHBE’s novel mechanism of action differs from GLP-1RAs. INHBE is identified through genome-wide association studies. Populations with loss of function in INHBE are associated with favorable fat distribution and beneficial metabolic characteristics[4]. Targeted inhibition of INHBE might be more conducive for long-term weight management at the genetic level with precisely lower visceral fat and favorable metabolic profiles.

CMS-D008 teams up with CMS-D005: highly effective weight loss plus long-term maintenance, building a more comprehensive weight-loss solution

CMS-D008 will synergize with CMS-D005, a self-developed innovative drug currently in clinical development. CMS-D008 reduces fat without sacrificing muscle mass by precisely inhibiting INHBE gene expression; while CMS-D005, as a GLP-1R/GCGR dual agonist, can effectively reduce liver fat while losing weight. The synergy between these two drugs will achieve highly effective weight loss benefits and long-term maintenance of results, jointly enhancing the Group’s R&D capabilities and product competitiveness in the field of obesity/metabolic treatment. Furthermore, leveraging the Group’s mature network resources in the field of cardiovascular and metabolic diseases, the drug’s R&D and commercialization process will be accelerated, providing patients with more comprehensive and innovative treatment options.

The Group is actively preparing to initiate relevant clinical trials and strives to launch the Product as soon as possible.

About CMS

CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.

CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.

CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardiovascular-kidney-metabolic/ gastroenterology/ ophthalmology/ skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group.

Reference:

  1. Chinese Society of Endocrinology. Guideline for chronic weight management and clinical practice of anti-obesity medications(2024 version). Chinese Journal of Endocrinology and Metabolism. 2024,40(7):545-564.
  2. World Obesity Federation. World Obesity Atlas 2025. London: World Obesity Federation, 2025. https://data.worldobesity.org/publications/?cat=23
  3. Zhikai Zheng, Yao Zong, Yiyang Ma, Yucheng Tian, Yidan Pang, Changqing Zhang, Junjie Gao. Glucagon-like peptide-1 receptor: mechanisms and advances in therapy. Sig Transduct Target Ther 9, 234 (2024). doi: 10.1038/s41392-024-01931-z
  4. Parsa Akbari, Olukayode A Sosina, Jonas Bovijn, et al. Multiancestry exome sequencing reveals INHBE mutations associated with favorable fat distribution and protection from diabetes. Nat Commun.2022 Aug 23;13(1):4844. doi: 10.1038/s41467-022-32398-7.

CMS Disclaimer and Forward-Looking Statements

This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.

This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.

Media Contact

Brand: China Medical System Holdings Ltd.

Contact: CMS Investor Relations

Email: ir@cms.net.cn

Website: https://web.cms.net.cn/en/home/

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Oberheiden P.C. Now Offering Nevada Asset Protection Trusts

Published

52 minutes ago

on

March 5, 2026

By

United States, 5th Mar 2026 – Oberheiden P.C. is pleased to announce that the firm’s asset protection attorneys are now offering Nevada asset protection trusts to clients nationwide. Nevada asset protection trusts are unique among domestic asset protection trusts (DAPTs) for their flexibility, and they can be powerful tools for insulating high-net-worth individuals’ assets from creditor claims both in and out of court.

According to the firm’s founding attorney, Dr. Nick Oberheiden, “While many high-net-worth individuals are familiar with the benefits afforded by offshore asset protection trusts, far fewer are familiar with the domestic options that are available. The Nevada asset protection trust can be a particularly good option for individuals who want to protect their assets within the United States while also taking advantage of the estate planning, tax planning, and other benefits that domestic trusts can afford.”

Dr. Oberheiden says that forming Nevada asset protection trust can be a particularly good option for several reasons. For example, while a Nevada asset protection trust is a type of irrevocable trust, a grantor (the individual who forms a trust) still has the ability to modify how they hold their assets over time. This distinguishes Nevada law from the laws of many other states. Nevada also has a shorter statute of limitations for creditor claims than most other states (two years in most cases), and Nevada law does not recognize any exception creditors.

“These factors, combined with the relative ease of forming a Nevada domestic asset protection trust, make using a Nevada DAPT a desirable option in a wide range of circumstances—including circumstances in which high-net-worth individuals might otherwise be looking at transferring assets into an offshore trust established in the Cook Islands or another foreign jurisdiction.” Dr. Oberheiden continues, “If you are interested in learning about your options for protecting your wealth from both known and unknown creditors, it will be worth talking to an attorney about whether a Nevada DAPT is a good option for your individual circumstances.”

While forming a Nevada DAPT involves leveraging the benefits afforded under the state’s trust laws, Dr. Oberheiden emphasizes that this is not solely an option for Nevada residents. “When the Nevada legislature adopted the state’s asset protection trust laws, it specifically opened up the possibility of forming a Nevada DAPT to individuals residing across the country. Although there are certain statutory requirements that make it important to work with a Nevada trust company, individuals nationwide can form statutory trusts in Nevada for asset protection purposes.”

Dr. Oberheiden is also quick to emphasize that while forming a Nevada DAPT is a desirable option in many cases, it is important for all high-net-worth individuals to make informed decisions about their asset protection needs based on their individual circumstances. “While forming a Nevada DAPT to protect real property and other assets will make sense for many individuals, it is important to consider the other options that are available as well. A few states offer self-settled spendthrift trust options that will meet individuals’ needs in some cases; and, in other cases, forming an offshore asset protection trust may be necessary to protect assets located around the world.”

“Additionally,” he continues, “limited liability companies and other vehicles can be used for asset protection as well. Purchasing liability insurance can be a cost-effective means of limiting high-net-worth individuals’ personal liability exposure as well. Ultimately, while we are now offering Nevada asset protection trusts, we are still focused on ensuring that we provide each of our clients with a custom-tailored solution focused on their specific risks and needs.”

Dr. Oberheiden says that high-net-worth individuals who are interested in learning about the options for safeguarding their assets in the U.S. and abroad are encouraged to contact the firm for a complimentary initial consultation. “We have a team of highly skilled asset protection attorneys who are committed to helping our clients protect their assets not only in the short term, but also for future generations.” He continues, “If you have questions, one of our attorneys will be more than happy to schedule a call to begin talking through your options in strict confidence.”

Nick Oberheiden, Founding Attorney, 888-680-1745 (Office)

Attorney Advertising – Oberheiden, P.C., is an asset protection law firm headquartered in Houston, TX with a nationwide network of senior attorneys and consultants. The firm’s asset protection attorneys are available to assist clients with Nevada asset protection trusts and other asset protection strategies throughout the United States. The firm’s addresses and contact information can be found at www.federal-lawyer.com/our-locations.

 

Media Contact

Organization: Oberheiden, P.C.

Contact Person: Nick Oberheiden, Founding Attorney

Website: https://federal-lawyer.com/asset-protection/

Email: Send Email

Contact Number: +18886801745

Country:United States

Release id:42208

Disclaimer: This press release is provided for general informational purposes only and does not constitute legal, financial, or professional advice.

The post Oberheiden P.C. Now Offering Nevada Asset Protection Trusts appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

file

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

SPL VPN Announces AI-Driven Architectural Shift to Replace Manual Server Routing

Published

1 hour ago

on

March 5, 2026

By

Dubai, UAE, 5th March 2026, ZEX PR WIRE, SPL VPN has announced an architectural transition to an AI-driven routing engine, effectively automating global server selection for its two million users. The shift replaces traditional manual configurations with a proprietary protocol designed to eliminate connection guesswork and latency issues.

As digital privacy requirements evolve, SPL VPN is prioritizing usability through a system that analyzes network congestion, ISP throttling, and packet loss in real-time. This “zero-touch” approach automatically builds optimized routes for specific traffic types, such as streaming or secure browsing, without user intervention.

The update features predictive reconnection technology, allowing the infrastructure to anticipate node failures and switch paths before a connection drop occurs. This technical advancement is reflected in the platform’s new adaptive interface, which simplifies the experience for over 500,000 daily active users by removing legacy server lists.

“The future of connectivity is a seamless layer that functions before the user identifies a need for it,” stated the Head of Product at SPL. “After eight years of development, we are moving beyond the industry’s traditional ‘server-count race’ toward a model of delivery intelligence.”

Established in 2018, SPL VPN has consistently combined encryption standards with emerging AI research. This latest expansion strengthens the company’s position as a utility-focused provider for the modern web, offering a faster and more intuitive framework for global digital security.

About SPL VPN

SPL VPN is a global provider of digital privacy solutions. Established in 2018 in Singapore, the company utilizes AI-driven routing and military-grade encryption to provide secure, high-performance internet access for over 2 million users worldwide.

Website: https://splvpn.com/

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

LATEST POST

Like Us
Follow Us
Subscribe Us
Follow Us